EP1578365A4 - Molecular interactions in neurons - Google Patents
Molecular interactions in neuronsInfo
- Publication number
- EP1578365A4 EP1578365A4 EP03768964A EP03768964A EP1578365A4 EP 1578365 A4 EP1578365 A4 EP 1578365A4 EP 03768964 A EP03768964 A EP 03768964A EP 03768964 A EP03768964 A EP 03768964A EP 1578365 A4 EP1578365 A4 EP 1578365A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- neurons
- molecular interactions
- interactions
- molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42621202P | 2002-11-14 | 2002-11-14 | |
US42621302P | 2002-11-14 | 2002-11-14 | |
US426212P | 2002-11-14 | ||
US426213P | 2002-11-14 | ||
PCT/US2003/036698 WO2004045535A2 (en) | 2002-11-14 | 2003-11-14 | Molecular interactions in neurons |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1578365A2 EP1578365A2 (en) | 2005-09-28 |
EP1578365A4 true EP1578365A4 (en) | 2009-09-23 |
Family
ID=32329101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03768964A Withdrawn EP1578365A4 (en) | 2002-11-14 | 2003-11-14 | Molecular interactions in neurons |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1578365A4 (en) |
CA (1) | CA2505479A1 (en) |
WO (1) | WO2004045535A2 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6942981B1 (en) | 1999-05-14 | 2005-09-13 | Arbor Vita Corporation | Method of determining interactions with PDZ-domain polypeptides |
US20040082509A1 (en) | 1999-10-12 | 2004-04-29 | Christophe Bonny | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
US8183339B1 (en) | 1999-10-12 | 2012-05-22 | Xigen S.A. | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
EP1709084A4 (en) * | 2003-12-23 | 2008-05-28 | Nono Inc | Polypeptides for modulating binding of trp channel proteins and trp-associated proteins |
DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
WO2007002395A1 (en) * | 2005-06-23 | 2007-01-04 | Arbor Vita Corporation | Methods and compositions for modulating cox |
US8080517B2 (en) | 2005-09-12 | 2011-12-20 | Xigen Sa | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
WO2007031098A1 (en) | 2005-09-12 | 2007-03-22 | Xigen S.A. | Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
US8633160B2 (en) * | 2005-12-30 | 2014-01-21 | Nono Inc. | Small molecule inhibitors of PDZ interactions |
EP2043671B1 (en) * | 2006-07-11 | 2020-05-20 | NoNO Inc. | Peptide and composition thereof for use in treating stroke with fever |
EP1884521A1 (en) * | 2006-07-31 | 2008-02-06 | Xigen S.A. | Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
US8008253B2 (en) | 2007-07-03 | 2011-08-30 | Andrew Tasker | Treatment for anxiety |
WO2009143864A1 (en) | 2008-05-30 | 2009-12-03 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases |
WO2009143865A1 (en) | 2008-05-30 | 2009-12-03 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
WO2010072228A1 (en) | 2008-12-22 | 2010-07-01 | Xigen S.A. | Novel transporter constructs and transporter cargo conjugate molecules |
DK2440231T3 (en) * | 2009-06-10 | 2020-01-13 | Nono Inc | CO-ADMINISTRATION OF AN AGENT BONDED TO A TAT INTERNALIZATION PERIOD WITH A MAST CELL DEGREANATION INHIBITOR |
PT2440230T (en) * | 2009-06-10 | 2021-02-03 | Nono Inc | Model systems and treatment regimes for treatment of neurological disease |
WO2011160653A1 (en) | 2010-06-21 | 2011-12-29 | Xigen S.A. | Novel jnk inhibitor molecules |
AU2010362444B2 (en) | 2010-10-14 | 2015-08-06 | Xigen Inflammation Ltd. | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases |
EP2581384A1 (en) | 2011-10-11 | 2013-04-17 | Institut Pasteur | Products useful for the treatment of malignant neoplasms of the human nervous system |
WO2013091670A1 (en) | 2011-12-21 | 2013-06-27 | Xigen S.A. | Novel jnk inhibitor molecules for treatment of various diseases |
WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
WO2015197097A1 (en) | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | New use for jnk inhibitor molecules for treatment of various diseases |
WO2014206427A1 (en) | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
CN106554386A (en) * | 2015-09-25 | 2017-04-05 | 广州恒上医药技术有限公司 | The epitope peptide of human papillomavirus and its application |
CN111712252A (en) | 2017-12-13 | 2020-09-25 | 纽约州立大学研究基金会 | Peptides and other agents for treating pain and increasing pain sensitivity |
CA3089649A1 (en) * | 2018-03-08 | 2019-09-12 | Phanes Therapeutics, Inc. | Anti-tip-1 antibodies and uses thereof |
CN114807142B (en) * | 2022-05-26 | 2024-03-29 | 源生生物科技(青岛)有限责任公司 | Annular RNA-circ-Magi1 and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2273622A1 (en) * | 1999-06-02 | 2000-12-02 | Michael Tymianski | Inhibition of nmda receptor signalling in reducing neuronal damage |
WO2002007751A1 (en) * | 2000-07-25 | 2002-01-31 | Axcell Biosciences Corporation | Identification and isolation of novel polypeptides having pdz domains and methods of using same |
WO2002057413A2 (en) * | 2001-01-18 | 2002-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for activation and inhibition of delta pkc |
WO2002090981A1 (en) * | 2001-05-08 | 2002-11-14 | Japan Science And Technology Corporation | Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
WO2003014303A2 (en) * | 2001-08-03 | 2003-02-20 | Arbor Vita Corporation | Molecular interactions in cells |
-
2003
- 2003-11-14 EP EP03768964A patent/EP1578365A4/en not_active Withdrawn
- 2003-11-14 CA CA002505479A patent/CA2505479A1/en not_active Abandoned
- 2003-11-14 WO PCT/US2003/036698 patent/WO2004045535A2/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2273622A1 (en) * | 1999-06-02 | 2000-12-02 | Michael Tymianski | Inhibition of nmda receptor signalling in reducing neuronal damage |
WO2002007751A1 (en) * | 2000-07-25 | 2002-01-31 | Axcell Biosciences Corporation | Identification and isolation of novel polypeptides having pdz domains and methods of using same |
WO2002057413A2 (en) * | 2001-01-18 | 2002-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for activation and inhibition of delta pkc |
WO2002090981A1 (en) * | 2001-05-08 | 2002-11-14 | Japan Science And Technology Corporation | Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
EP1391729A1 (en) * | 2001-05-08 | 2004-02-25 | Japan Science and Technology Corporation | Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
WO2003014303A2 (en) * | 2001-08-03 | 2003-02-20 | Arbor Vita Corporation | Molecular interactions in cells |
Non-Patent Citations (4)
Title |
---|
AARTS MICHELLE ET AL: "Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, WASHINGTON, DC, vol. 298, no. 5594, 25 October 2002 (2002-10-25), pages 846 - 850, XP002456870, ISSN: 0036-8075 * |
KORNAU H-C ET AL: "Domain Interaction Between NMDA Receptor Subunits and the Postsynaptic Density Protein PSD-95", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, WASHINGTON, DC, vol. 269, no. 5231, 1 September 1995 (1995-09-01), pages 1737 - 1740, XP002196675, ISSN: 0036-8075 * |
LIM I A ET AL: "Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM, US, vol. 277, no. 24, 14 June 2002 (2002-06-14), pages 21697 - 21698, XP002991766, ISSN: 0021-9258 * |
ROUSSET R ET AL: "THE C-TERMINUS OF THE HTLV-1 TAX ONCOPROTEIN MEDIATES INTERACTION WITH THE PDZ DOMAIN OF CELLULAR PROTEINS", ONCOGENE, NATURE PUBLISHING GROUP, GB BASINGSTOKE, HANTS, vol. 16, no. 5, 5 February 1998 (1998-02-05), pages 643 - 654, XP000865909, ISSN: 0950-9232 * |
Also Published As
Publication number | Publication date |
---|---|
EP1578365A2 (en) | 2005-09-28 |
CA2505479A1 (en) | 2004-06-03 |
WO2004045535A3 (en) | 2006-07-13 |
WO2004045535A2 (en) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1578365A4 (en) | Molecular interactions in neurons | |
AU2003228850A8 (en) | Single trial detection in encephalography | |
AU2003294503A8 (en) | Molecular nephrotoxicology modeling | |
GB2418259B (en) | Improvements in touch technology | |
EP1443951A4 (en) | Molecular interactions in cells | |
GB2392946B (en) | Improvements in control units | |
AU2003268003A8 (en) | Diamondoid-based components in nanoscale construction | |
DE60333033D1 (en) | Pulverförmiges thermoplastisches polymer | |
GB2393446B (en) | Polymer | |
EP1501722A4 (en) | Improvements in bowsprits | |
AU2003235768A8 (en) | Molecular trichogram | |
AU2003239679A1 (en) | Improvements in greetins cards | |
EP1487547A4 (en) | Physical interaction means and related uses thereof | |
GB2428804B (en) | Improvements in touch technology | |
GB0311936D0 (en) | Improvements in devices | |
GB2396429B (en) | Elasticity in plastics processing | |
GB0221366D0 (en) | Molecular model | |
GB0201593D0 (en) | Ferromagnetic polymer | |
GB0321462D0 (en) | Molecular model | |
AU2003900493A0 (en) | Improvements in lock - cont 4 | |
AU2003900103A0 (en) | Improvements in lock - Cont 3 | |
AU2003900725A0 (en) | Improvements in lock - cont 5 | |
GB0204072D0 (en) | Music once you step in | |
GB0324811D0 (en) | Improvements in magnetopolariscopes | |
AU2003900838A0 (en) | Improvements in lock - Cont. 6 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050530 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 38/06 20060101ALI20060907BHEP Ipc: A61K 38/04 20060101ALI20060907BHEP Ipc: A61K 38/00 20060101ALI20060907BHEP Ipc: A01N 37/18 20060101AFI20060907BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090821 |
|
17Q | First examination report despatched |
Effective date: 20091209 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110215 |